NextAR Spine Platform
K-Number: K233172 · 2024-04-24
ApplicantMedacta International S.A.
Decision Date2024-04-24
Product CodeSBF
Advisory CommitteeNE
DecisionSubstantially Equivalent
Device Summary
NextAR Spine Platform is a medical device manufactured by Medacta International S.A.. It received FDA 510(k) clearance on 2024-04-24 under approval number K233172. The device is classified under product code SBF. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the NextAR Spine Platform?
NextAR Spine Platform is a medical device that received FDA 510(k) clearance on 2024-04-24. It is manufactured by Medacta International S.A.. The 510(k) number is K233172.
When was NextAR Spine Platform approved by the FDA?
NextAR Spine Platform received FDA 510(k) clearance on 2024-04-24, under approval number K233172.
What company makes NextAR Spine Platform?
NextAR Spine Platform is manufactured by Medacta International S.A..
What is the FDA product code for NextAR Spine Platform?
The FDA product code for NextAR Spine Platform is SBF.
Other Devices by Medacta International S.A.
Related Devices (Code: SBF)
K190929xvision Spine system (XVS)Augmedics, Ltd.
K202152NextAR TKA PlatformMedacta International S.A.
K193559NextAR TKA PlatformMedacta Inernational SA
K210859NextAR Spine PlatformMedacta International S.A.
K211188xvision Spine system (XVS)Augmedics, Ltd.
K210153NextAR RSA PlatformMedacta International S.A.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.